8-K 1 p64910e8-k.txt 8-K 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 26, 2001 -------------- DRUG EMPORIUM, INC. (Exact name of registrant as specified in its charter) Delaware 0-16998 31-1064888 (State or Other Jurisdiction (Commission (IRS Employer Incorporation) File Number) Identification No.) 155 HIDDEN RAVINES DRIVE, POWELL, OHIO 43065 (Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code (740) 548-7080 -------------- Not applicable (Former name or former address, if changed since last report.) 2 ITEM 3. BANKRUPTCY OR RECEIVERSHIP On March 27, 2001, Drug Emporium, Inc., a Delaware corporation (the "Company"), issued a press release announcing that the Company and its subsidiaries filed a petition for reorganization under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the Northern District of Ohio on March 26, 2001. The press release is furnished as Exhibit 99.1 to this Form 8-K. The information contained in the press release is incorporated herein by reference. The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the press release, dated March 27, 2001, attached hereto. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (c) Exhibits.

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant bas duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DRUG EMPORIUM, INC. Date: April 3, 2001 By: /s/ Terry L. Moore -------------------------------- Terry L. Moore Chief Financial Officer 3 EXHIBIT INDEX

Filing Compare · DRUG EMPORIUM INC